BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38627415)

  • 21. PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.
    Turk AA; Wisinski KB
    Cancer; 2018 Jun; 124(12):2498-2506. PubMed ID: 29660759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trim33 is essential for macrophage and neutrophil mobilization to developmental or inflammatory cues.
    Demy DL; Tauzin M; Lancino M; Le Cabec V; Redd M; Murayama E; Maridonneau-Parini I; Trede N; Herbomel P
    J Cell Sci; 2017 Sep; 130(17):2797-2807. PubMed ID: 28724755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival.
    Herrero AB; Gutiérrez NC
    Front Oncol; 2017; 7():98. PubMed ID: 28580318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage production and activation are dependent on TRIM33.
    Gallouet AS; Ferri F; Petit V; Parcelier A; Lewandowski D; Gault N; Barroca V; Le Gras S; Soler E; Grosveld F; Davidson I; Romeo PH
    Oncotarget; 2017 Jan; 8(3):5111-5122. PubMed ID: 27974684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability.
    Pommier RM; Gout J; Vincent DF; Alcaraz LB; Chuvin N; Arfi V; Martel S; Kaniewski B; Devailly G; Fourel G; Bernard P; Moyret-Lalle C; Ansieau S; Puisieux A; Valcourt U; Sentis S; Bartholin L
    Cancer Res; 2015 Oct; 75(20):4335-50. PubMed ID: 26282171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stability.
    Herrero AB; San Miguel J; Gutierrez NC
    PLoS One; 2015; 10(3):e0121581. PubMed ID: 25790254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.
    Gong F; Chiu LY; Cox B; Aymard F; Clouaire T; Leung JW; Cammarata M; Perez M; Agarwal P; Brodbelt JS; Legube G; Miller KM
    Genes Dev; 2015 Jan; 29(2):197-211. PubMed ID: 25593309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly(ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein.
    Kulkarni A; Oza J; Yao M; Sohail H; Ginjala V; Tomas-Loba A; Horejsi Z; Tan AR; Boulton SJ; Ganesan S
    J Biol Chem; 2013 Nov; 288(45):32357-32369. PubMed ID: 23926104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional intermediary factor 1γ binds to the anaphase-promoting complex/cyclosome and promotes mitosis.
    Sedgwick GG; Townsend K; Martin A; Shimwell NJ; Grand RJ; Stewart GS; Nilsson J; Turnell AS
    Oncogene; 2013 Sep; 32(39):4622-33. PubMed ID: 23160376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.
    Boyd KD; Ross FM; Walker BA; Wardell CP; Tapper WJ; Chiecchio L; Dagrada G; Konn ZJ; Gregory WM; Jackson GH; Child JA; Davies FE; Morgan GJ;
    Clin Cancer Res; 2011 Dec; 17(24):7776-84. PubMed ID: 21994415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.
    Neri P; Ren L; Gratton K; Stebner E; Johnson J; Klimowicz A; Duggan P; Tassone P; Mansoor A; Stewart DA; Lonial S; Boise LH; Bahlis NJ
    Blood; 2011 Dec; 118(24):6368-79. PubMed ID: 21917757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia.
    Aucagne R; Droin N; Paggetti J; Lagrange B; Largeot A; Hammann A; Bataille A; Martin L; Yan KP; Fenaux P; Losson R; Solary E; Bastie JN; Delva L
    J Clin Invest; 2011 Jun; 121(6):2361-70. PubMed ID: 21537084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma.
    Herquel B; Ouararhni K; Khetchoumian K; Ignat M; Teletin M; Mark M; Béchade G; Van Dorsselaer A; Sanglier-Cianférani S; Hamiche A; Cammas F; Davidson I; Losson R
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8212-7. PubMed ID: 21531907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult hematopoiesis is regulated by TIF1γ, a repressor of TAL1 and PU.1 transcriptional activity.
    Kusy S; Gault N; Ferri F; Lewandowski D; Barroca V; Jaracz-Ros A; Losson R; Romeo PH
    Cell Stem Cell; 2011 Apr; 8(4):412-25. PubMed ID: 21474105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIF1gamma controls erythroid cell fate by regulating transcription elongation.
    Bai X; Kim J; Yang Z; Jurynec MJ; Akie TE; Lee J; LeBlanc J; Sessa A; Jiang H; DiBiase A; Zhou Y; Grunwald DJ; Lin S; Cantor AB; Orkin SH; Zon LI
    Cell; 2010 Jul; 142(1):133-43. PubMed ID: 20603019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo.
    Morsut L; Yan KP; Enzo E; Aragona M; Soligo SM; Wendling O; Mark M; Khetchoumian K; Bressan G; Chambon P; Dupont S; Losson R; Piccolo S
    Development; 2010 Aug; 137(15):2571-8. PubMed ID: 20573697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletions of CDKN2C in multiple myeloma: biological and clinical implications.
    Leone PE; Walker BA; Jenner MW; Chiecchio L; Dagrada G; Protheroe RK; Johnson DC; Dickens NJ; Brito JL; Else M; Gonzalez D; Ross FM; Chen-Kiang S; Davies FE; Morgan GJ
    Clin Cancer Res; 2008 Oct; 14(19):6033-41. PubMed ID: 18829482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
    Qazilbash MH; Saliba RM; Ahmed B; Parikh G; Mendoza F; Ashraf N; Hosing C; Flosser T; Weber DM; Wang M; Couriel DR; Popat U; Kebriaei P; Alousi AM; Anderlini P; Naeem RC; Champlin RE; Giralt SA
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1066-72. PubMed ID: 17697969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.
    Shaughnessy JD; Zhan F; Burington BE; Huang Y; Colla S; Hanamura I; Stewart JP; Kordsmeier B; Randolph C; Williams DR; Xiao Y; Xu H; Epstein J; Anaissie E; Krishna SG; Cottler-Fox M; Hollmig K; Mohiuddin A; Pineda-Roman M; Tricot G; van Rhee F; Sawyer J; Alsayed Y; Walker R; Zangari M; Crowley J; Barlogie B
    Blood; 2007 Mar; 109(6):2276-84. PubMed ID: 17105813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis.
    Ransom DG; Bahary N; Niss K; Traver D; Burns C; Trede NS; Paffett-Lugassy N; Saganic WJ; Lim CA; Hersey C; Zhou Y; Barut BA; Lin S; Kingsley PD; Palis J; Orkin SH; Zon LI
    PLoS Biol; 2004 Aug; 2(8):E237. PubMed ID: 15314655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.